Q3 FY26 standalone loss of Rs 6.6 cr; revenue down 12.8% YoY
NIPPOBATRY · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.4 pts less than Nifty Microcap 250 and 1.4 pts more than its Household Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Indo-National (Nippo) reported a Q3 FY26 standalone loss of Rs 6.6 cr versus a profit of Rs 63 lakh YoY. Revenue fell 12.8 percent to Rs 106.1 cr from Rs 121.6 cr. Nine month standalone PAT swung to a Rs 2.3 cr loss from Rs 3.6 cr profit. Consolidated 9 month PAT was a Rs 5.7 cr loss against Rs 121.9 cr profit (last year included a large one time gain from sale of Composites business). Company invested Rs 5.7 cr for 46.76 percent in Medcuore Medical and Rs 8.5 cr in Axial Aero CCPS. Q3 EPS at negative Rs 8.83.
Weak quarter with revenue decline and swing to loss. Watch margin recovery; ongoing CCI penalty appeal of Rs 42 cr remains a risk.